Skip to main content
. 2017 Jan 31;2017(1):CD010941. doi: 10.1002/14651858.CD010941.pub2

4.16. Analysis.

4.16

Comparison 4 Individual tailored versus continuous tapered dexamethasone regimen, Outcome 16 Abnormal neurodevelopmental outcome in survivors assessed (various definitions).